These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia? Kondziella D; Brenner E; Eyjolfsson EM; Sonnewald U Neurochem Int; 2007 Jan; 50(2):291-301. PubMed ID: 17084946 [TBL] [Abstract][Full Text] [Related]
46. Cognitive impairment of executive function as a core symptom of schizophrenia. Wobrock T; Ecker UK; Scherk H; Schneider-Axmann T; Falkai P; Gruber O World J Biol Psychiatry; 2009; 10(4 Pt 2):442-51. PubMed ID: 18609418 [TBL] [Abstract][Full Text] [Related]
47. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex. Elsworth JD; Groman SM; Jentsch JD; Leranth C; Redmond DE; Kim JD; Diano S; Roth RH Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522392 [TBL] [Abstract][Full Text] [Related]
48. An integrated neuropathophysiological model of schizophrenia. Holden TJ Med Hypotheses; 1989 Feb; 28(2):109-13. PubMed ID: 2927352 [TBL] [Abstract][Full Text] [Related]
49. Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Bernstein HG; Steiner J; Bogerts B Expert Rev Neurother; 2009 Jul; 9(7):1059-71. PubMed ID: 19589054 [TBL] [Abstract][Full Text] [Related]
50. Pathogenesis of schizophrenic delusions and hallucinations: a neural model. Ruppin E; Reggia JA; Horn D Schizophr Bull; 1996; 22(1):105-23. PubMed ID: 8685653 [TBL] [Abstract][Full Text] [Related]
51. Neurocognitive models of schizophrenia: a neurophenomenological critique. Gallagher S Psychopathology; 2004; 37(1):8-19. PubMed ID: 14988645 [TBL] [Abstract][Full Text] [Related]
52. Schizophrenia: an information processing model. Carr V; Wale J Aust N Z J Psychiatry; 1986 Jun; 20(2):136-55. PubMed ID: 3464263 [TBL] [Abstract][Full Text] [Related]
53. Negative v positive schizophrenia. Definition and validation. Andreasen NC; Olsen S Arch Gen Psychiatry; 1982 Jul; 39(7):789-94. PubMed ID: 7165478 [TBL] [Abstract][Full Text] [Related]
54. Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism. Ragland JD; Yoon J; Minzenberg MJ; Carter CS Int Rev Psychiatry; 2007 Aug; 19(4):417-27. PubMed ID: 17671874 [TBL] [Abstract][Full Text] [Related]
55. Sex-specific differences in cognitive functioning among schizophrenic patients. Krysta K; Murawiec S; Klasik A; Wiglusz MS; Krupka-Matuszczyk I Psychiatr Danub; 2013 Sep; 25 Suppl 2():S244-6. PubMed ID: 23995185 [TBL] [Abstract][Full Text] [Related]
56. Cognitive function in schizophrenia: conflicting findings and future directions. Moustafa AA; Garami JK; Mahlberg J; Golembieski J; Keri S; Misiak B; Frydecka D Rev Neurosci; 2016 Jun; 27(4):435-48. PubMed ID: 26756090 [TBL] [Abstract][Full Text] [Related]
57. The loss of ego boundaries in schizophrenia: a neuromolecular hypothesis. Mitterauer B Med Hypotheses; 2001 May; 56(5):614-21. PubMed ID: 11388777 [TBL] [Abstract][Full Text] [Related]
58. Experimental Medicine in Psychiatry New Approaches in Schizophrenia, Depression and Cognition. Dawson GR Curr Top Behav Neurosci; 2016; 28():475-97. PubMed ID: 27418068 [TBL] [Abstract][Full Text] [Related]
59. Toward a prefrontal microcircuit model for cognitive deficits in schizophrenia. Wang XJ Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S80-7. PubMed ID: 16508903 [TBL] [Abstract][Full Text] [Related]